Discontinued Operations and Disposal Groups - Schedule of Statement of Operations (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jul. 01, 2023	Jul. 02, 2022	Jul. 01, 2023	Jul. 02, 2022
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Loss on deconsolidation	$ (60,639)	$ (60,639)	$ 60,639	$ (60,639)
Non-refundable payments	10,150	10,150	10,150	10,150
Disposed of by Sale | Carti Heal
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]
Selling, general and administrative expense	0	0	1,728	0
Research and development expense	0	0	396	0
Change in fair value of contingent consideration	0	0	1,710	0
Depreciation and amortization	0	0	4,264	0
Operating loss from discontinued operations	0	0	(8,098)	0
Interest expense, net	0	0	4,889	0
Other expense	0	280	61,442	681
Other expense	0	280	66,331	681
Loss before income taxes	0	(280)	(74,429)	(681)
Income tax benefit, net	0	0	0	0
Net loss	0	(280)	(74,429)	(681)
Loss attributable to noncontrolling interest	0	0	14,937	0
Net loss attributable to Bioventus Inc.	$ 0	$ (280)	$ (59,492)	$ (681)